Advances in the Management of R/R cHL

 

ASH 2021 Conference Coverage on VuMedi
A

ASH 2021 Five-Year Follow-Up of Keynote-087: Pembrolizumab Monotherapy in R/R cHL

By ASH 2021 Conference Coverage on VuMedi FEATURING Alex Herrera
By ASH 2021 Conference Coverage on VuMedi FEATURING Alex Herrera
271 views
March 24, 2022
0 Comments
Login to view comments. Click here to Login
Advances in the Management of R/R cHL
16:08
John Kuruvilla

KEYNOTE-204 in R/R cHL: How Does This Trial Influence Our Practice?

07:23
ASH 2021 Conference Coverage on VuMedi

ASH 2021 Five-Year Follow-Up of Keynote-087: Pembrolizumab Monothera…

Feat. A. Herrera
17:03
Stephen M. Ansell

PD-1 Blockade in Hodgkin Lymphoma: Moving Up the Ranks

16:04
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Integrating Novel Agents Into the Treatment of Classic HL

Feat. A. LaCasce
08:50
UNC Lineberger Comprehensive Cancer Center

Latest Advances in the Management of R/R cHL: The Era of Novel Thera…

Feat. N. Grover
23:57
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022

Advanced Stage Hodgkin Lymphoma in 2022: Common Management Issues

Feat. C. Moskowitz
41:23
University of Colorado Division of Hematology

UC Denver ASH Review: Updates on Lymphomas

Feat. S. Bair
17:09
Penn Medicine Abramson Cancer Center

Therapeutic Advances in Hodgkin Lymphoma

Feat. J. Svoboda
29:12
Penn Medicine Abramson Cancer Center

Equitable Access to Hematologic Malignancies Research for Everyone

Feat. C. Guerra
54:37
19th Annual International Ultmann Chicago Lymphoma Symposium

Toxicities Associated With Chronic Therapies for Lymphoma: Case Stud…

Feat. N. Soriano, K. Thorp